Search

everythinglearnresearchcommunity

for

Search:↓

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

RCM and OCT are effective for diagnosing and monitoring hair-related skin diseases but lack standardized protocols and need more research.

IFNγ-primed MSC secretomes can improve joint health by reducing inflammation and supporting tissue repair.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

COVID-19 mRNA vaccines may increase the risk of flare-ups in certain inflammatory diseases.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

Azathioprine caused side effects in over half of the Korean pediatric inflammatory bowel disease patients, requiring close monitoring.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

Platelet-released growth factors can reduce inflammation in joint disease.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Inflammasome proteins may help diagnose and treat Parkinson's disease.

Higher inflammation markers are linked to more severe alopecia areata.

Hidradenitis suppurativa may involve gut and oral bacteria, suggesting targeted treatments could help.

Bee venom shows promise for treating cancer, infections, inflammation, and hair loss.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

Fibroblasts are crucial for tissue repair and inflammation, and understanding them can help treat fibrotic diseases.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

AGA patients have higher heart disease risk.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.